27572277|t|Gut microbiota after Roux-en-Y gastric bypass and sleeve gastrectomy in a diabetic rat model: Increased diversity and associations of discriminant genera with metabolic changes
27572277|a|Recent work with gut microbiota after bariatric surgery is limited, and the results have not been in agreement. Given the role of the gut microbiota in regulating host metabolism, we explored the effect of Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) on the modifications of gut microbiota with regard to the potential influence of food intake and/or weight loss and examined their links with host metabolism. Zucker diabetic fatty rats were divided into the following groups: RYGB; sham-operated with pair-fed as RYGB; sham-operated fed ad libitum; and SG. The metabolic effects and gut microbiota profile were analyzed 10 weeks postoperatively. Associations between discriminating genera and metabolic markers after RYGB were explored. The 2 procedures induced similar glucose improvement and increased flora diversity after 10 weeks compared with sham-operated groups. RYGB induced a marked higher relative abundance of Proteobacteria / Gammaproteobacteria and Betaproteobacteria and increased emergence of Fusobacteria and Clostridium, whereas SG resulted in more abundant Actinobacteria compared with other groups. Most of the 12 discriminant genera correlated with changes in metabolic phenotype, but only 28.6% of these correlations were independent of weight, and 4 discriminant genera still negatively correlated with serum insulin level independent of food intake and weight loss after RYGB. These data demonstrate that RYGB and SG surgery produced similar diversity but different microbiota compositions changes in Zucker diabetic fatty rats. These findings stimulate deeper explorations of functions of the discriminate microbiota and the mechanisms linking postsurgical modulation of gut microbiota and improvements in insulin resistance.
27572277	0	14	Gut microbiota	T001	C2985398
27572277	21	45	Roux-en-Y gastric bypass	T061	C0585179
27572277	50	68	sleeve gastrectomy	T061	C3160799
27572277	74	82	diabetic	T047	C0011847
27572277	83	86	rat	T015	C0034721
27572277	87	92	model	T050	C0012644
27572277	104	113	diversity	T080	C1880371
27572277	134	146	discriminant	T080	C0205235
27572277	147	153	genera	T185	C1708235
27572277	159	168	metabolic	T040	C0025519
27572277	169	176	changes	T169	C0392747
27572277	194	208	gut microbiota	T001	C2985398
27572277	215	232	bariatric surgery	T061	C1456587
27572277	311	325	gut microbiota	T001	C2985398
27572277	340	344	host	T001	C1167395
27572277	345	355	metabolism	T040	C0025519
27572277	383	407	Roux-en-Y gastric bypass	T061	C0585179
27572277	409	413	RYGB	T061	C0585179
27572277	419	437	sleeve gastrectomy	T061	C3160799
27572277	439	441	SG	T061	C3160799
27572277	467	481	gut microbiota	T001	C2985398
27572277	524	528	food	T168	C0016452
27572277	529	535	intake	T169	C1512806
27572277	543	549	weight	T032	C0005910
27572277	550	554	loss	T081	C1517945
27572277	550	554	loss	T081	C1517945
27572277	585	589	host	T001	C1167395
27572277	590	600	metabolism	T040	C0025519
27572277	609	617	diabetic	T047	C0011847
27572277	618	628	fatty rats	T015	C0034721
27572277	661	667	groups	T078	C0441833
27572277	669	673	RYGB	T061	C0585179
27572277	675	688	sham-operated	T061	C0032042
27572277	706	710	RYGB	T061	C0585179
27572277	712	725	sham-operated	T061	C0032042
27572277	746	748	SG	T061	C3160799
27572277	754	771	metabolic effects	T039	C2945675
27572277	776	790	gut microbiota	T001	C2985398
27572277	791	798	profile	T169	C2003903
27572277	804	812	analyzed	T062	C0936012
27572277	816	821	weeks	T079	C0439230
27572277	860	874	discriminating	T080	C0205235
27572277	875	881	genera	T185	C1708235
27572277	886	903	metabolic markers	T123	C1513159
27572277	910	914	RYGB	T061	C0585179
27572277	936	946	procedures	T061	C0087111
27572277	963	970	glucose	T109,T121,T123	C0017725
27572277	971	982	improvement	T077	C2986411
27572277	997	1002	flora	T001	C2985398
27572277	1003	1012	diversity	T080	C1880371
27572277	1022	1027	weeks	T079	C0439230
27572277	1028	1036	compared	T052	C1707455
27572277	1042	1055	sham-operated	T061	C0032042
27572277	1064	1068	RYGB	T061	C0585179
27572277	1115	1129	Proteobacteria	T007	C0751985
27572277	1132	1151	Gammaproteobacteria	T007	C0751988
27572277	1156	1174	Betaproteobacteria	T007	C0751987
27572277	1202	1214	Fusobacteria	T007	C1222477
27572277	1219	1230	Clostridium	T007	C0009054
27572277	1240	1242	SG	T061	C3160799
27572277	1269	1283	Actinobacteria	T007	C0600148
27572277	1284	1292	compared	T052	C1707455
27572277	1327	1339	discriminant	T080	C0205235
27572277	1340	1346	genera	T185	C1708235
27572277	1347	1357	correlated	T080	C1707520
27572277	1363	1370	changes	T169	C0392747
27572277	1374	1383	metabolic	T040	C0025519
27572277	1384	1393	phenotype	T032	C0031437
27572277	1419	1431	correlations	T080	C1707520
27572277	1452	1458	weight	T032	C0005910
27572277	1466	1478	discriminant	T080	C0205235
27572277	1479	1485	genera	T185	C1708235
27572277	1503	1513	correlated	T080	C1707520
27572277	1519	1538	serum insulin level	T034	C1261415
27572277	1554	1558	food	T168	C0016452
27572277	1559	1565	intake	T169	C1512806
27572277	1570	1576	weight	T032	C0005910
27572277	1577	1581	loss	T081	C1517945
27572277	1588	1592	RYGB	T061	C0585179
27572277	1600	1604	data	T078	C1511726
27572277	1622	1626	RYGB	T061	C0585179
27572277	1631	1633	SG	T061	C3160799
27572277	1634	1641	surgery	T169	C0038895
27572277	1659	1668	diversity	T080	C1880371
27572277	1683	1693	microbiota	T001	C2985398
27572277	1725	1733	diabetic	T047	C0011847
27572277	1734	1744	fatty rats	T015	C0034721
27572277	1794	1803	functions	T040	C0025519
27572277	1811	1823	discriminate	T080	C0205235
27572277	1824	1834	microbiota	T001	C2985398
27572277	1843	1853	mechanisms	T169	C0441712
27572277	1862	1874	postsurgical	T079	C1254367
27572277	1875	1885	modulation	T082	C0443264
27572277	1889	1903	gut microbiota	T001	C2985398
27572277	1908	1920	improvements	T077	C2986411
27572277	1924	1942	insulin resistance	T046	C0021655